These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27189971)

  • 21. Delayed activation of PPAR-β/δ improves long-term survival in mouse sepsis: effects on organ inflammation and coagulation.
    Busch D; Kapoor A; Rademann P; Hildebrand F; Bahrami S; Thiemermann C; Osuchowski MF
    Innate Immun; 2018 May; 24(4):262-273. PubMed ID: 29697010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
    Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic inflammation after haemorrhagic shock.
    Yin L; Busch D; Qiao Z; van Griensven M; Teuben M; Hildebrand F; Pape HC; Pfeifer R
    Cytokine; 2018 Mar; 103():127-132. PubMed ID: 28969938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.
    Hong K; Li M; Nourian Z; Meininger GA; Hill MA
    Hypertension; 2017 Dec; 70(6):1264-1272. PubMed ID: 29061726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered reactivity of resistance vasculature contributes to hypertension in elastin insufficiency.
    Osei-Owusu P; Knutsen RH; Kozel BA; Dietrich HH; Blumer KJ; Mecham RP
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H654-66. PubMed ID: 24414067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
    Park JB; Schiffrin EL
    Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
    Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
    Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.
    Yue TL; Nerurkar SS; Bao W; Jucker BM; Sarov-Blat L; Steplewski K; Ohlstein EH; Willette RN
    J Pharmacol Exp Ther; 2008 May; 325(2):466-74. PubMed ID: 18287212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
    Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.
    Harrington LS; Moreno L; Reed A; Wort SJ; Desvergne B; Garland C; Zhao L; Mitchell JA
    PLoS One; 2010 Mar; 5(3):e9526. PubMed ID: 20209098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.
    Ozawa C; Horiguchi M; Akita T; Oiso Y; Abe K; Motomura T; Yamashita C
    Biol Pharm Bull; 2016; 39(5):778-85. PubMed ID: 27150147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
    Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control.
    Patel J; Chuaiphichai S; Douglas G; Gorvin CM; Channon KM
    Vascul Pharmacol; 2018 Sep; 108():15-22. PubMed ID: 29654907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin.
    Wagner N; Jehl-Piétri C; Lopez P; Murdaca J; Giordano C; Schwartz C; Gounon P; Hatem SN; Grimaldi P; Wagner KD
    Cardiovasc Res; 2009 Jul; 83(1):61-71. PubMed ID: 19351742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.
    Holobotovskyy V; Manzur M; Tare M; Burchell J; Bolitho E; Viola H; Hool LC; Arnolda LF; McKitrick DJ; Ganss R
    Circ Res; 2013 Mar; 112(5):781-91. PubMed ID: 23303165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
    Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
    Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.